Shares of Medicenna Therapeutics Corp. (TSE:MDNA - Get Free Report) hit a new 52-week low on Friday . The company traded as low as C$1.01 and last traded at C$1.03, with a volume of 30290 shares. The stock had previously closed at C$1.01.
Medicenna Therapeutics Stock Performance
The firm has a market capitalization of C$68.83 million, a P/E ratio of -2.53 and a beta of 1.21. The stock has a fifty day simple moving average of C$1.38 and a two-hundred day simple moving average of C$1.81. The company has a debt-to-equity ratio of 0.88, a current ratio of 11.40 and a quick ratio of 4.65.
Insider Activity
In other news, Senior Officer David Hyman acquired 20,000 shares of the firm's stock in a transaction dated Thursday, January 9th. The stock was purchased at an average price of C$1.45 per share, for a total transaction of C$29,000.00. Corporate insiders own 22.57% of the company's stock.
About Medicenna Therapeutics
(
Get Free Report)
Medicenna Therapeutics Corp is a Canada based immuno-oncology company. Its principal business activity is the development and commercialization of Empowered Cytokines and Superkines for the treatment of cancer. The company is engaged in developing Interleukin-4 Empowered Cytokines that specifically target the Interleukin-4 Receptor which is over-expressed by 20 different cancers, cancer stem cells and immunosuppressive cells of the tumor microenvironment.
Further Reading
Before you consider Medicenna Therapeutics, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Medicenna Therapeutics wasn't on the list.
While Medicenna Therapeutics currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for March 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
